Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 30, 2023

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation And Qualifying Accounts

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Description	Balance at beginning of period		Charged to costs and expenses		Deductions		Balance at end of period
December 30, 2023
Allowance for sales returns	$	572	$	5,552	$	5,704	$	420
Allowance for credit losses	$	363	$	112	$	54	$	421
Valuation allowance - deferred tax assets	$	118,136	$	19,116	$	—	$	137,252
December 31, 2022
Allowance for sales returns	$	547	$	6,562	$	6,537	$	572
Allowance for credit losses	$	504	$	6	$	147	$	363
Valuation allowance - deferred tax assets	$	99,958	$	18,178	$	—	$	118,136
January 1, 2022
Allowance for sales returns	$	819	$	7,213	$	7,485	$	547
Allowance for credit losses	$	372	$	148	$	16	$	504
Valuation allowance - deferred tax assets	$	81,401	$	18,557	$	—	$	99,958